Spruce Biosciences (SPRB) announced the appointment of Dale Hooks as chief commercial officer. Hooks joins the company with nearly 35 years of pharmaceutical marketing and sales experience, including commercial leadership roles for 21 new product launches. Hooks previously served as chief commercial officer of Applied Therapeutics and was responsible for leading the company’s commercial preparations in two rare diseases.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on SPRB:
- Biotech Alert: Searches spiking for these stocks today
- Regulatory De-Risking and Extended Runway Underpin Maintained Buy Rating on Spruce Biosciences
- Spruce Biosciences price target lowered to $200 from $220 at H.C. Wainwright
- Spruce Biosciences provides update on Type B tralesinidase meetings with FDA
- 3 ‘Strong Buy’ Stocks to Buy Now, 2/6/2026, According to Top Analysts